Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Placebo-Controlled, Double-blind Phase 2 Study to Evaluate the Short-term Efficacy, Safety and Tolerance and to Find an Optimal Dosage of the PENNEL Capsule for the Patients With Chronic Liver Disease

NCT01393665 is registered in ClinicalTrials.gov with PharmaKing as lead sponsor.

NCT NCT01393665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01393665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Placebo-Controlled, Double-blind Phase 2 Study to Evaluate the Short-term Efficacy, Safety and Tolerance and to Find an Optimal Dosage of the PENNEL Capsule for the Patients With Chronic Liver Disease
Lead sponsor
PharmaKing
Phase
Phase 2
Overall status
Completed
Start date
December 31, 1996
Completion date
October 31, 1997
Enrollment
88 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease